Comparison of Radiofrequency Ablation and Cryotherapy for the Treatment of Barrett's Esophagus With High-Grade Dysplasia and/or Early Adenocarcinoma
| Status: | Completed |
|---|---|
| Conditions: | Gastrointestinal |
| Therapuetic Areas: | Gastroenterology |
| Healthy: | No |
| Age Range: | 21 - Any |
| Updated: | 4/2/2016 |
| Start Date: | November 2013 |
| End Date: | February 2016 |
| Contact: | Norman S Nishioka, MD |
| Email: | nnishioka@partners.org |
| Phone: | 6177264422 |
Prospective Randomized Trial Comparing Radiofrequency Ablation (Barrx™) and Cryotherapy (TruFreeze™) for the Treatment of Barrett's Esophagus With High-Grade Dysplasia and/or Early Adenocarcinoma
The two treatment modalities under investigation are clinically equivalent (non-inferior) to
each other for the endoscopic treatment of Barrett's esophagus with HGD and/or early
esophageal adenocarcinoma.
each other for the endoscopic treatment of Barrett's esophagus with HGD and/or early
esophageal adenocarcinoma.
Inclusion Criteria:
- suitable candidates for endoscopic treatment of Barrett's esophagus (BE) with
high-grade dysplasia (HGD) and/or early adenocarcinoma of the esophagus
Exclusion Criteria:
- contraindications to endoscopic treatment (e.g., bleeding diathesis, pregnancy,
severe medical comorbidities, advanced liver disease)
- refusal to participate in the study
We found this trial at
1
site
Click here to add this to my saved trials
